Moreover, neutralizing this pro-inflammatory IL-17 has been associated with a reduced insulitis score in the effector phase of disease development in NOD mice, suggesting a role for this cytokine and immune activation within pathogenesis of T1D (33). Here, IL17A is linked to type 1 diabetes mellitus.